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Aim of Study: In osteoarthritis (OA), catabolic factors like 
Interleukin-1 (IL-1) and Tumor Necrosis Factor (TNF) have a di- 
rect effect on chondrocytes by stimulating the production of ma- 
trix degrading enzymes including Aggrecanases and metallopro- 
teases resulting in proteoglycan and collagen degradation, re- 
spectively. Protein Kinase C (PKC) is a family of serine/threonine 
kinases divided into three major groups: conventional, novel and 
atypical. PKC-zeta (PKCz) is a member of the atypical PKC and 
controls important cellular functions through the regulation of crit- 
ical signaling pathways. The aim of this study is to understand the 
role of PKCz in IL-1/TNF pathways in chondrocytes. 
Methods: PKCz expression in cartilage: RNA was extracted from 
frozen pulverized articular cartilage tissue from normal and OA 
specimens and subjected to gene expression profiling analysis. 
For further confirmation of gene expression, quantitative PCR 
analysis was performed. 
NF-kB-luciferase cell line: Human chondrocyte cell line T/C-28a2 
was transfected with NF-kB response elements coupled to lu- 
ciferase gene and a stable cell line (T/C-NFkB-luci) was selected 
which responded to IL-1/TNF stimulation. 
PKCz expression in chondrocytes: Primary chondrocytes were 
isolated from both bovine and human cartilage. Cells were stimu- 
lated with IL-1/TNF in the absence or presence of PKC inhibitors. 
Expression of aggrecanase was analyzed by quantitative PCR. 
Results: PKCz expression was increased in OA cartilage: Re- 
sults from gene expression profiling studies showed that in rela- 
tion to normal cartilage, PKCz expression was increased in OA 
cartilage. The results were further confirmed using quantitative 
PCR. 
PKCz inhibitors inhibited IL-1/TNF induced NF-kB: Human chon- 
drocytic ell line, T/C-NFkB-luci stimulated with IL-1/TNF showed 
increased luciferase activity in the luciferase reporter assay in- 
dicating the activation of NF-kB in chondrocytes. Inhibitors of 
PKCz, but not PKCz-sparing inhibitors inhibited luciferase activity 
indicating the regulation of NF-kB signaling by PKCz. 
Inhibition of PKCz downregulated aggrecanase expression: Pri- 
mary chondrocytes timulated with IL-1/TNF upregulated aggre- 
canase expression. Addition of PKCz inhibitors resulted in the 
downregulation of aggrecanase xpression. 
Conclusions: PKCz provides a unique opportunity to study the 
regulation of IL-1 and TNF signaling pathways in chondrocytes. 
Our results show that PKCz is involved in the regulation of IL- 
1/TNF induced NF-kB signaling which in turn regulates the down- 
stream expression of aggrecanase. Therefore, inhibition of PKCz 
could potentially regulate the production of degradative nzymes 
and have a profound effect on the disease progression in OA. 
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Aims: ADAMTS-4 and -5 have been shown to be the enzymes re- 
sponsible for aggrecan degradation in articular cartilage explant 
cultures treated with IL-1, and to exist as a number of isoforms 
with differing proteolytic activities and specificities. The objective 
of this study was to analyse ADAMTS-4 and -5 secretion and ac- 
tivation in articular cartilage explant cultures treated with varying 
doses of IL-1. 
Methods: Porcine articular cartilage explants were cultured in 
DMEM with or without 10 or 100ng/ml IL-1 and harvested after 
4, 7 and 10 days. The DMMB assay was used to measure GAG 
release and media samples were analysed for aggrecanase- 
generated IGD aggrecan catabolites by Western blotting with 
M'Ab BC-3. Isoforms of ADAMTS-4 and -5 in media samples 
were detected using M'Ab Anti-ADAMTS-4N, recognising the 
metalloproteinase domain of ADAMTS-4 and polyclonal antibody 
Anti-ADAMTS-5 Catalytic domain, respectively. 
Results: GAG release to the medium was highest in cul- 
tures treated with 100ng/ml IL-1, and higher in cultures treated 
with 10ng/ml IL-1 than in Control cultures. Increased GAG re- 
lease corresponded with increased detection of aggrecanase- 
generated IGD aggrecan catabolites by Western blotting using 
BC-3. ADAMTS-4 isoforms were detected at 45, 37 and 30kD 
using Anti-ADAMTS-4N. ADAMTS-5 isoforms were detected at 
42, 37 and 30kD using Anti-ADAMTS-5 Catalytic domain. The 
45kD isoform of ADAMTS-4 and the 42kD isoform of ADAMTS-5 
were detected at equal intensity in all cultures. The co-migrating 
37kD isoforms of ADAMTS-4 and -5 were detected at increased 
intensity in cultures treated with 10ng/ml IL-I. Interestingly, higher 
MW isoforms of ADAMTS-4 and -5 were detected (at 68 and 
70kD, respectively) only in media samples from cultures treated 
with 100ng/ml IL-I. These higher molecular weight isoforms of 
ADAMTS-4 and -5 were detected at increased intensity with in- 
creasing time in the presence of 100ng/ml IL-I. However, these 
isoforms were not detectable in cultures treated with 10ng/ml IL-1 
even after 10 days treatment. 
Conclusion: The co-migrating 37kD isoforms of ADAMTS-4 and 
-5 detected at increased intensity in explants treated with 10ng/ml 
IL-1 suggests a role for these low MW isoforms in the IGD aggre- 
canase activity detected in these cultures. However, these co- 
migrating 37kD isoforms of ADAMTS-4 and -5 are not detected 
at higher levels in media samples from explants treated with 
100ng/ml IL-1 than those treated with 10ng/ml IL-1, despite the 
detection of increased IGD aggrecanase activity in these cultures. 
This implies the higher MW, possibly full length furin-activated iso- 
forms of ADAMTS-4 and -5 (68 and 70kD, respectively) detected 
in explants treated with 100ng/ml IL-1, to be in part responsible 
for the IGD aggrecanase activity detected in these cultures. This 
data indicates different doses of IL-1 may have differing effects 
on the isoforms of ADAMTS-4 and -5 present in explant cultures 
and their IGD aggrecanase activity 
